Skip to content

OCULUS INC.: 10-Q filed 2022-11-04

What OCULUS INC. reported in its quarterly report filed 2022-11-04 (fiscal Q3 2022): 21 published measures, 61 facts as tagged in accession 0001437749-22-025922.

This filing

Form
10-Q (quarterly report)
Filed
2022-11-04
Fiscal period
fiscal Q3 2022
Accession
0001437749-22-025922 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All OCULUS INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-09-301,043,111USD
At 2021-12-312,246,283USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-09-30763,372USD
At 2022-06-301,230,329USD
At 2021-12-312,123,660USD
At 2021-09-302,471,299USD
At 2021-06-302,880,736USD
At 2020-12-31328,205USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-09-301,019,957USD
At 2021-12-312,208,451USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-524,699USD92
2022-01-01 to 2022-09-30-1,649,986USD273
2021-01-01 to 2021-12-31-1,986,665USD365
2021-07-01 to 2021-09-30-578,810USD92
2021-01-01 to 2021-09-30-1,456,171USD273
2020-01-01 to 2020-12-31-2,772,484USD366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-1,141,131USD273
2021-01-01 to 2021-09-30-845,776USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-09-300USD273
2021-01-01 to 2021-09-303,062,246USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-09-30-47,795,831USD
At 2021-12-31-46,145,845USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-07-01 to 2022-09-3091,422,569shares92
2022-01-01 to 2022-09-3091,422,569shares273
2021-07-01 to 2021-09-3091,422,569shares92
2021-01-01 to 2021-09-3089,476,981shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-0.01USD/shares92
2022-01-01 to 2022-09-30-0.02USD/shares273
2021-07-01 to 2021-09-30-0.01USD/shares92
2021-01-01 to 2021-09-30-0.02USD/shares273

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-09-30336,107USD273
2021-01-01 to 2021-09-30537,019USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-09-30279,739USD
At 2021-12-31122,623USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-09-30229,537USD
At 2021-12-3161,836USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2022-07-01 to 2022-09-30116,163USD92
2022-01-01 to 2022-09-30310,987USD273
2021-07-01 to 2021-09-30113,607USD92
2021-01-01 to 2021-09-30319,132USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-07-01 to 2022-09-30283,269USD92
2022-01-01 to 2022-09-30912,892USD273
2021-07-01 to 2021-09-30295,830USD92
2021-01-01 to 2021-09-30575,999USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-09-3091,422,569shares
At 2021-12-3191,422,569shares
At 2021-09-3091,422,569shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-09-301,334,584USD
At 2021-12-31998,477USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-09-3023,154USD
At 2021-12-3137,832USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-547,224USD92
2022-01-01 to 2022-09-30-1,696,395USD273
2021-07-01 to 2021-09-30-578,810USD92
2021-01-01 to 2021-09-30-1,456,171USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-01-01 to 2022-09-30106,963USD273
2021-01-01 to 2021-09-30128,300USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2022-01-01 to 2022-09-300USD273
2021-01-01 to 2021-09-300USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2022-01-01 to 2022-09-300USD273
2021-01-01 to 2021-09-303,098,616USD273

Inspect the source

Entity
OCULUS INC. / CIK 0001107280
Captured
2026-09-20T05:23:31.283Z
SEC response SHA-256
63097be359140327b7dc122e8108372f9ed2c94e74a857e52ba6271b22125468

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001107280.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))